Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DEMIRE adjusts guidance due to larger portfolio base and lower costs
-
DEMIRE passt Prognose aufgrund größerer Portfoliobasis und niedrigerer Kosten an
-
Zug, 03 November 2025 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized enterprises, and other FinTechs (WKN:...
-
TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company...
-
ROUYN-NORANDA, Quebec, Nov. 27, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
-
Multitude AG: Chief Executive Officer Antti Kumpulainen, Acquisition Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely...
-
Zug, 19 November 2025 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized enterprises, and other FinTechs (WKN:...
-
Zug, 13. November 2025 – Die Multitude AG (WKN: A40VJN, ISIN: CH1398992755), ein börsennotiertes europäisches FinTech-Unternehmen, das digitale Kredit- und Online-Banking-Dienstleistungen für...
-
Zug, 13 November 2025 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized enterprises, and other FinTechs (WKN:...
-
TORONTO and HAIFA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that, further to its...